Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00974415 · ClinicalTrials.gov registry record · NA

Study of the Carbon Dioxide Treatment for Fat Reduction

A NA study of Overweight, sponsored by Northwestern University.

Active
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT00974415: Active NA study of Overweight, sponsored by Northwestern University.

NCT00974415 is a NA study of Overweight that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 25 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00974415, a NA study of Overweight, is active but no longer recruiting, sponsored by Northwestern University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to demonstrate the efficacy and safety of the carbon dioxide for subcutaneous fat reduction.

Conditions Studied

Interventions

  • PROCEDURE Sham
  • PROCEDURE CO2

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2010-01
Est. Completion 2025-12
Phase NA
Northwestern University

1,209 total trials

What the registry record for NCT00974415 still lists

NCT00974415 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Overweight appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.

NCT00974415 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT00974415 about?

NCT00974415 is a clinical study titled "Study of the Carbon Dioxide Treatment for Fat Reduction". The primary objective of this study is to demonstrate the efficacy and safety of the carbon dioxide for subcutaneous fat reduction.

What is the current status of trial NCT00974415?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2010-01. Estimated completion is 2025-12.

What conditions does trial NCT00974415 study?

This clinical trial studies the following conditions: Overweight.

What interventions are being tested in trial NCT00974415?

The interventions under investigation include: Sham (PROCEDURE), CO2 (PROCEDURE).

Who is sponsoring clinical trial NCT00974415?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00974415 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00974415's enrollment target sits among peer trials

25 176th of 197 higher than 20 of 197 other Overweight trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00974415, the US trial registry maintained by the National Library of Medicine. NCT00974415 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.